Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study
Fifth Affiliated Hospital of Sun Yat-sen University · Sun Yat-sen University
Indexed incrossrefdoajpubmed
Abstract
No abstract available for this paper.
Citation impact
526
total citations
- FWCI
- 13.17
- Percentile
- 100%
- References
- 27
Citations per year
Authors
8- LDLisi Deng
Fifth Affiliated Hospital of Sun Yat-sen University, Sun Yat-sen University
- CLChunna Li
Fifth Affiliated Hospital of Sun Yat-sen University, Sun Yat-sen University
- QZQi Zeng
Sun Yat-sen University, Fifth Affiliated Hospital of Sun Yat-sen University
- XLXi Liu
Sun Yat-sen University, Fifth Affiliated Hospital of Sun Yat-sen University
- XLXinghua Li
Sun Yat-sen University, Fifth Affiliated Hospital of Sun Yat-sen University
Topics & keywords
Topics
Keywords
- Lopinavir
- Medicine
- Ritonavir
- Retrospective cohort study
- Coronavirus disease 2019 (COVID-19)
- Internal medicine
- Lopinavir/ritonavir
- Clinical endpoint
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.